Clarigo is a CE marked non-invasive prenatal test (NIPT) solution, specifically designed for implementation in local clinical laboratories to enable NIPT for all. This simple, robust and highly reliable test screens for the trisomy status of chromosome 21, 18 and 13 early in pregnancy. It is compatible with a variety of Next-Generation Sequencing (NGS) systems and offers the lab the flexibility to run from 10 to 192 samples in 1 run.
CE-Marked products are only available in Europe.
For In Vitro Diagnostic Use